InsidersTradesSigma
Everest Medicines Ltd.: insider trades · Hong Kong · HKEX
HKEX:everest-medicines-ltdHK·HKEXMcap 10.8Bn€Healthcare
Discover the full insider trade history of Everest Medicines Ltd., a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, Everest Medicines Ltd. has logged 8 public disclosures. Market capitalisation: €10.8bn. The latest transaction was reported on 14 May 2026 — Purchase. Among the most active insiders: Wu Yifang. Every trade is free.
8
Insider Decl.
0
Thresholds
€4m
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
30.84 €
Analyst consensus
7 analystsBuy
25.43 €Target 49.63 €(+61%)68.64 €
Income statement
Revenue1.71 Bn€
Gross profit1.18 Bn€69% margin
Net income−297.8 M€-17.4% margin
Valuation
PER (forward)26.6x
P/Book1.8x
Beta1.54
Balance sheet & cash
Market cap10.84 Bn€
Total debt926.3 M€
Free Cash Flow−440.9 M€
Debt / Equity17%
Profitability & ownership
ROE-6.4%
ROA-3.6%
% insiders0.8%
% institutions39.4%
Last declaration on 14 May 2026
Declarations8 total
8 of 8 declarations